Louisiana State Employees Retirement System Amgen Inc Transaction History

Louisiana State Employees Retirement System

$5.21 Billion
Q4 2024

A detailed history of Louisiana State Employees Retirement System transactions in Amgen Inc stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 68,100 shares of AMGN stock, worth $19.9 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

68,100

Previous 71,300 4.49%

Holding current value

$19.9 Million

Previous $23 Million 22.74%

% of portfolio

0.34%

Previous 0.43%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$258.78 - $328.31 $828,095 - $1.05 Million	-3,200 Reduced 4.49%	68,100 $17.7 Million
Q3 2024 Oct 23, 2024	SELL	$309.38 - $337.38 $495,008 - $539,808	-1,600 Reduced 2.19%	71,300 $23 Million
Q2 2024 Jul 24, 2024	SELL	$262.75 - $319.31 $52,550 - $63,862	-200 Reduced 0.27%	72,900 $22.8 Million
Q1 2024 Apr 23, 2024	SELL	$268.87 - $324.56 $483,966 - $584,208	-1,800 Reduced 2.4%	73,100 $20.8 Million
Q4 2023 Jan 29, 2024	SELL	$255.7 - $288.46 $127,850 - $144,230	-500 Reduced 0.66%	74,900 $21.6 Million
Q3 2023 Oct 17, 2023	BUY	$218.65 - $271.46 $1.95 Million - $2.42 Million	8,900 Added 13.38%	75,400 $20.3 Million
Q2 2023 Jul 18, 2023	BUY	$214.27 - $253.37 $1.11 Million - $1.32 Million	5,200 Added 8.48%	66,500 $14.8 Million
Q1 2023 Apr 19, 2023	BUY	$225.79 - $275.2 $67,737 - $82,560	300 Added 0.49%	61,300 $14.8 Million
Q4 2022 Jan 24, 2023	SELL	$229.03 - $291.01 $458,060 - $582,020	-2,000 Reduced 3.17%	61,000 $16 Million
Q3 2022 Oct 19, 2022	BUY	$224.46 - $253.15 $134,676 - $151,890	600 Added 0.96%	63,000 $14.2 Million
Q2 2022 Jul 20, 2022	SELL	$230.71 - $256.74 $645,988 - $718,872	-2,800 Reduced 4.29%	62,400 $15.4 Million
Q4 2021 Jan 14, 2022	BUY	$198.88 - $227.6 $99,440 - $113,800	500 Added 0.77%	65,200 $14.7 Million
Q3 2021 Oct 12, 2021	SELL	$212.27 - $248.7 $169,816 - $198,960	-800 Reduced 1.22%	64,700 $13.8 Million
Q2 2021 Jul 16, 2021	SELL	$233.58 - $259.14 $46,716 - $51,828	-200 Reduced 0.3%	65,500 $16 Million
Q1 2021 Apr 14, 2021	BUY	$221.91 - $258.6 $909,831 - $1.06 Million	4,100 Added 6.66%	65,700 $16.3 Million
Q4 2020 Jan 11, 2021	BUY	$216.38 - $257.67 $6.9 Million - $8.22 Million	31,900 Added 107.41%	61,600 $14.2 Million
Q3 2020 Oct 19, 2020	BUY	$234.65 - $260.95 $1.03 Million - $1.15 Million	4,400 Added 17.39%	29,700 $7.55 Million
Q1 2020 Apr 13, 2020	SELL	$182.24 - $241.7 $528,496 - $700,930	-2,900 Reduced 10.28%	25,300 $5.13 Million
Q4 2019 Jan 17, 2020	SELL	$189.21 - $243.2 $113,526 - $145,920	-600 Reduced 2.08%	28,200 $6.8 Million
Q3 2019 Oct 24, 2019	SELL	$174.11 - $208.62 $313,398 - $375,516	-1,800 Reduced 5.88%	28,800 $5.57 Million
Q2 2019 Jul 15, 2019	SELL	$166.7 - $195.41 $383,410 - $449,443	-2,300 Reduced 6.99%	30,600 $5.35 Million
Q1 2019 Apr 15, 2019	SELL	$180.87 - $203.88 $90,435 - $101,940	-500 Reduced 1.5%	32,900 $6.25 Million
Q4 2018 Jan 14, 2019	SELL	$178.4 - $208.25 $802,800 - $937,125	-4,500 Reduced 11.87%	33,400 $6.5 Million
Q3 2018 Oct 16, 2018	SELL	$185.29 - $208.89 $240,877 - $271,557	-1,300 Reduced 3.32%	37,900 $7.86 Million
Q2 2018 Jul 18, 2018	SELL	$166.05 - $186.51 $265,680 - $298,416	-1,600 Reduced 3.92%	39,200 $7.24 Million
Q1 2018 Apr 18, 2018	SELL	$169.43 - $198.0 $525,233 - $613,800	-3,100 Reduced 7.06%	40,800 $6.96 Million
Q4 2017 Jan 16, 2018	SELL	$168.79 - $188.59 $286,943 - $320,603	-1,700 Reduced 3.73%	43,900 $7.63 Million
Q3 2017 Oct 16, 2017	BUY	$167.29 - $191.0 $7.63 Million - $8.71 Million	45,600	45,600 $8.5 Million

Others Institutions Holding AMGN

# of Institutions

3,154

Shares Held

417M

Call Options Held

8.32M

Put Options Held

6.47M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.

Account

Louisiana State Employees Retirement System Amgen Inc Transaction History